| PARP inhibitors in cancer diagnosis and therapy CY Chan, KV Tan, B Cornelissen Clinical Cancer Research 27 (6), 1585-1594, 2021 | 70 | 2021 |
| Rhenium and technetium tricarbonyl complexes of N-heterocyclic carbene ligands CY Chan, PA Pellegrini, I Greguric, PJ Barnard Inorganic Chemistry 53 (20), 10862-10873, 2014 | 52 | 2014 |
| Rhenium (i) complexes of N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's disease CY Chan, A Noor, CA McLean, PS Donnelly, PJ Barnard Chemical communications 53 (15), 2311-2314, 2017 | 28 | 2017 |
| Rhenium complexes of bidentate, bis-bidentate and tridentate N-heterocyclic carbene ligands CY Chan, PJ Barnard Dalton Transactions 44 (44), 19126-19140, 2015 | 23 | 2015 |
| Copper-Mediated Radiosynthesis of [18F]Rucaparib Z Chen, G Destro, F Guibbal, CY Chan, B Cornelissen, V Gouverneur Organic letters 23 (18), 7290-7294, 2021 | 19 | 2021 |
| Copper-based reactions in analyte-responsive fluorescent probes for biological applications HY Au-Yeung, CY Chan, KY Tong, ZH Yu Journal of Inorganic Biochemistry 177, 300-312, 2017 | 18 | 2017 |
| Imaging PARP with [18F]rucaparib in pancreatic cancer models CY Chan, Z Chen, G Destro, M Veal, D Lau, E O’Neill, G Dias, M Mosley, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (11), 3668-3678, 2022 | 12 | 2022 |
| A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy G Destro, Z Chen, CY Chan, C Fraser, G Dias, M Mosley, F Guibbal, ... Nuclear Medicine and Biology 116, 108312, 2023 | 8 | 2023 |
| [123I] CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer CY Chan, Z Chen, F Guibbal, G Dias, G Destro, E O’Neill, M Veal, D Lau, ... Journal of Nuclear Medicine 64 (12), 1965-1971, 2023 | 4 | 2023 |
| Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma CY Chan, SL Hopkins, F Guibbal, A Pacelli, J Baguña Torres, M Mosley, ... EJNMMI research 12 (1), 67, 2022 | 4 | 2022 |
| Non-invasive PET/MR imaging in an orthotopic mouse model of hepatocellular carcinoma KV Tan, X Yang, CY Chan, J Shi, HC Chang, KWH Chiu, K Man JoVE (Journal of Visualized Experiments), e63958, 2022 | 2 | 2022 |
| Imaging PARP with 18F-rucaparib CY Chan, Z Chen, G Destro, M Veal, D Lau, E O’Neill, G Dias, M Mosley, ... Journal of Nuclear Medicine 62 (supplement 1), 1516-1516, 2021 | 1 | 2021 |
| Investigating the effects of homologous recombination deficiency on radiotherapy response in pre-clinical prostate cancer PEE Kwon J, Murphy EA, Chan C, Afolaranmi S, Phyu SM, Bryant RJ EUROPEAN UROLOGY 83, 2023 | | 2023 |
| Radiopharmaceutical for Radionuclide Therapy of Cancer CY Chan, Z Chen, F Guibbal, G Dias, G Destro, E O’Neill, M Veal, D Lau, ... | | 2023 |
| Synthesis, Radiosynthesis, and In Vitro Evaluation of an Iodine-123 agent for Targeted Radionuclide Therapy of PARP-expressing Tumours G Destro, Z Chen, C Chan, G Dias, C Fraser, M Mosley, E O'Neill, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| [I-123] CC1: A Potent Auger Electron Emitting PARP-Targeting Theragnostic Agent B Cornelissen, C Chan, Z Chen, G Destro, M Veal, D Lau, E O'Neill, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent CR Fraser, J Ajenjo, M Veal, GM Dias, C Chan, E O’Neill, G Destro, D Lau, ... EJNMMI research 12 (1), 50, 2022 | | 2022 |
| Radiofluorination of A Highly Potent ATM Inhibitor As A Potential PET Imaging Agent J Ajenjo, M Veal, G Dias, C Chan, E O’Neill, G Destro, D Lau, A Pacelli, ... | | 2022 |
| PET Imaging Using [18F] olaparib in Mouse Models of Malignant Glioma: Considerations for Molecular Imaging and Radionuclide Therapy Targeting PARP CY Chan, SL Hopkins, F Guibbal, A Pacelli, JB Torres, M Mosley, D Lau, ... | | 2021 |
| Copper-Mediated Radiosynthesis of [¹⁸F] Rucaparib Z Chen, G Destro, F Guibbal, CY Chan, B Cornelissen, V Gouverneur | | 2021 |
Bart CornelissenUniversity Medical Centre Groningen / University of OxfordVerified email at oncology.ox.ac.uk
